JP Morgan Chase
USNA icon

JP Morgan Chase’s Usana Health Sciences USNA Stock Holding History

JP Morgan Chase’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.6K Sell
4,445
-44
-1% -$873 ﹤0.01% 5963
2025
Q4 		$88.1K Sell
4,489
-4,915
-52% -$102K ﹤0.01% 5954
2025
Q3 		$259K Sell
9,404
-507
-5% -$15.6K ﹤0.01% 5376
2025
Q2 		$303K Sell
9,911
-8,024
-45% -$228K ﹤0.01% 5024
2025
Q1 		$484K Sell
17,935
-1,188
-6% -$37.6K ﹤0.01% 4800
2024
Q4 		$686K Sell
19,123
-9,574
-33% -$358K ﹤0.01% 4878
2024
Q3 		$1.09M Sell
28,697
-36,062
-56% -$1.48M ﹤0.01% 4418
2024
Q2 		$2.93M Sell
64,759
-7,301
-10% -$336K ﹤0.01% 3454
2024
Q1 		$3.49M Sell
72,060
-57,180
-44% -$2.8M ﹤0.01% 3398
2023
Q4 		$6.93M Buy
129,240
+5,369
+4% +$272K ﹤0.01% 2812
2023
Q3 		$7.26M Sell
123,871
-11,767
-9% -$736K ﹤0.01% 2543
2023
Q2 		$8.55M Buy
135,638
+54,011
+66% +$3.44M ﹤0.01% 2422
2023
Q1 		$5.13M Buy
81,627
+5,848
+8% +$349K ﹤0.01% 2789
2022
Q4 		$4.03M Sell
75,779
-10,188
-12% -$552K ﹤0.01% 3007
2022
Q3 		$4.82M Buy
85,967
+1,987
+2% +$131K ﹤0.01% 2776
2022
Q2 		$6.08M Sell
83,980
-6,527
-7% -$486K ﹤0.01% 2610
2022
Q1 		$7.19M Sell
90,507
-686
-0.8% -$61.8K ﹤0.01% 2685
2021
Q4 		$9.23M Buy
91,193
+5,137
+6% +$512K ﹤0.01% 2523
2021
Q3 		$7.93M Sell
86,056
-2,915
-3% -$280K ﹤0.01% 2610
2021
Q2 		$9.11M Buy
88,971
+42,457
+91% +$4.26M ﹤0.01% 2503
2021
Q1 		$4.54M Sell
46,514
-8,807
-16% -$802K ﹤0.01% 3049
2020
Q4 		$4.26M Buy
55,321
+4,006
+8% +$310K ﹤0.01% 2949
2020
Q3 		$3.71M Buy
51,315
+5,934
+13% +$476K ﹤0.01% 2800
2020
Q2 		$3.33M Sell
45,381
-749
-2% -$58.8K ﹤0.01% 2759
2020
Q1 		$2.67M Sell
46,130
-50,511
-52% -$3.51M ﹤0.01% 2753
2019
Q4 		$7.59M Buy
96,641
+33,636
+53% +$2.48M ﹤0.01% 2356
2019
Q3 		$4.31M Buy
63,005
+28,224
+81% +$1.9M ﹤0.01% 2825
2019
Q2 		$2.67M Sell
34,781
-77,123
-69% -$6.12M ﹤0.01% 3180
2019
Q1 		$9.38M Buy
111,904
+58,121
+108% +$6.07M ﹤0.01% 2110
2018
Q4 		$6.33M Buy
53,783
+964
+2% +$111K ﹤0.01% 2381
2018
Q3 		$6.37M Buy
52,819
+9,062
+21% +$1.12M ﹤0.01% 2557
2018
Q2 		$5.04M Buy
43,757
+1,481
+4% +$162K ﹤0.01% 2677
2018
Q1 		$3.63M Buy
42,276
+22,335
+112% +$1.73M ﹤0.01% 2836
2017
Q4 		$1.48M Buy
19,941
+2,501
+14% +$167K ﹤0.01% 3497
2017
Q3 		$1M Buy
17,440
+1,055
+6% +$62.3K ﹤0.01% 3517
2017
Q2 		$1.05M Buy
16,385
+341
+2% +$21K ﹤0.01% 3402
2017
Q1 		$924K Buy
16,044
+196
+1% +$11.7K ﹤0.01% 3447
2016
Q4 		$970K Buy
15,848
+698
+5% +$45.5K ﹤0.01% 3463
2016
Q3 		$1.05M Sell
15,150
-31,306
-67% -$2.07M ﹤0.01% 3112
2016
Q2 		$2.59M Sell
46,456
-29,822
-39% -$1.8M ﹤0.01% 2674
2016
Q1 		$4.63M Sell
76,278
-175,782
-70% -$10.3M ﹤0.01% 2264
2015
Q4 		$16.1M Sell
252,060
-1,108
-0.4% -$71.9K ﹤0.01% 1493
2015
Q3 		$17M Buy
253,168
+78,804
+45% +$5.57M ﹤0.01% 1383
2015
Q2 		$11.9M Sell
174,364
-5,968
-3% -$379K ﹤0.01% 1801
2015
Q1 		$10M Sell
180,332
-11,848
-6% -$607K ﹤0.01% 1897
2014
Q4 		$9.86M Buy
192,180
+27,666
+17% +$1.36M ﹤0.01% 1956
2014
Q3 		$6.06M Sell
164,514
-1,082
-0.7% -$39K ﹤0.01% 2237
2014
Q2 		$6.47M Sell
165,596
-100,196
-38% -$3.72M ﹤0.01% 1954
2014
Q1 		$10M Buy
265,792
+23,694
+10% +$828K ﹤0.01% 1724
2013
Q4 		$9.15M Buy
242,098
+73,650
+44% +$2.82M ﹤0.01% 1820
2013
Q3 		$7.31M Sell
168,448
-18,142
-10% -$728K ﹤0.01% 1950
2013
Q2 		$6.75M Buy
+186,590
New +$5.67M ﹤0.01% 1923

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's USNA Position: Q1 2026 in Review

JP Morgan Chase reduced its Usana Health Sciences (USNA) stake by 0.98% in Q1 2026, selling an estimated $873 and leaving 4,445 shares worth $78.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5963.

JP Morgan Chase first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $17M in Q3 2015. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • JP Morgan Chase held 4,445 shares of Usana Health Sciences worth $78.6K as of Q1 2026.
  • JP Morgan Chase sold 44 Usana Health Sciences shares in Q1 2026, an estimated $873.
  • Usana Health Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5963 holding.
  • JP Morgan Chase first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Usana Health Sciences position peaked at $17M in Q3 2015.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.